New diabetes clinical trial: Semaglutide and Physical Activity for Obesity and Multimorbidity
Published on: January 31, 2024 at 10:30AM Conditions : Obesity Morbid; Multimorbidity; Obesity Interventions : Combination Product: Semaglutide 2.4 mg, total diet replacement, behavioural intervention Sponsors : Hvidovre University Hospital Not yet recruiting https://ift.tt/mW9hMwK